Razvan Nutiu MSc, PhD

Razvan Nutiu is an Investigator in the Department of Chemical Biology and Therapeutics, Novartis, Cambridge, USA, where he currently coordinates a research group focused on targeting modulating RNA biology with small molecules. At Novartis, Razvan has built expertise in integrated small molecule lead discovery, from target identification to assay development, high throughput screening, and identification of the compound mechanism of action.